We are international
Donate

1 Comment

regarding bisphosphonate use with myeloma, there is always mention of ONJ but never the atypical complete or incomplete femoral fractures that can result from bisphophonate use. What is the present standard of care for the treatment of incomplete bisphophonate related femoral stress fractures? I am aware that they are rare and all articles tend to relate to post menopausal women but as a myeloma patient for over 22 years, I have now developed one.

Leave a comment